Delayed Methotrexate clearance due to acute kidney injury is an oncologic emergency^1-3

Only Voraxaze® (glucarpidase) can lower methotrexate (MTX) levels by ≥97% in 15 minutes, reducing the risk for severe toxicities and death. 1,3-5

Act Early

Early treatment with Voraxaze resulted in significantly lower rates of toxicity and mortality.^1,6

View Efficacy

Review hospitalization outcomes based on actual Medicare claims data for patients treated with Voraxaze.⁷

View Hospital Outcomes With Voraxaze

See if your patient is clearing MTX as expected.

Learn How to Use MTXPK.org

Why Stock Voraxaze

Voraxaze lowers plasma MTX  by ≥97% in 15 minutes.5

High-Dose Methotrexate (HDMTX) Toxicity and Acute Kidney Injury

Keep Voraxaze top-of-mind when treating with HDMTX.

Identify and Treat Delayed MTX Clearance Early

Consensus Guidelines recommend early use of Voraxaze.2